13 eredmények
FIELD OF THE INVENTION
The invention in the field of biochemistry and medicine relates to combination therapy of cancer using compounds of the hydroxytolan (HT) family in combination with ascorbate and naphthoquinone (Vitamin K.sub.3 or "VK.sub.3") or a quinone or semiquinone analogue of
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention in the field of biochemistry and medicine is directed to the prevention and treatment of human cancer by administration of a combination of magnesium ascorbate (magnesium Vitamin C or "MgVC.sub.2") and the naphthoquinone Vitamin K3
BACKGROUND OF THE INVENTION
A. Field of invention
The present invention relates generally to methods of therapeutically treating cancer and more particularly to a new and improved method of administering ascorbic acid as a therapeutic agent.
B. Description of Related Art
In the treatment of cancer,
This invention relates to ascorbate complexes of platinum(II) coordinated to a monodentate or bidentate amine ligand in a cis configuration. Specifically, this invention relates to cis-platinum(II) amine ascorbate complexes in which the amine moiety is derived from ammonia or a monodentate or
This invention relates to a pharmaceutical composition in which the active ingredient is an ascorbate complex of platinum(II). More particularly, this invention relates to pharmaceutical compositions comprised of a cis-platinum(II) amine ascorbate complex in which the amine moiety is derived from
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention in the field of biochemistry and medicine relates to anti-cancer compounds of the hydroxytolan family, and methods of killing tumor cells, inhibiting tumor growth and development, and treating cancer in subjects in need thereof
FIELD OF THE INVENTION
The present invention relates to a effective depletion method of blood plasma ascorbate, by using ascorbate oxidase modified with biologically inert polymers.
DESCRIPTION OF THE PRIOR ART
<Desirability of L-ascorbic acid(LAA) in vivo manipulation for
BACKGROUND
Most treatment plans for patients with cancer include surgery, radiation therapy, and/or chemotherapy. Early clinical trials were performed for the use of vitamin C (ascorbic acid) to treat cancer, but epidemiological studies evaluating the association between the intake of vitamin C and
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to a use of micronutrient formulations to reduce the effects of radiation on humans.
Description of the Related Art
Ionizing radiation (X-rays and gamma rays) has proven to be a double-edged sword in clinical Medicine since
FIELD OF INVENTION
The present invention relates to substances and compositions for the prevention and treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as including but not limited to degenerative diseases, particularly arteriosclerosis,
1. FIELD OF INVENTION
The invention relates to a novel composition of matter--trimetrexate ascorbate--and to methods of its preparation and use. The invention is further related to compositions comprising trimetrexate ascorbate, to compositions comprising trimetrexate and ascorbic acid, and to
1. FIELD OF INVENTION
The invention relates to a novel composition of matter--trimetrexate ascorbate--and to methods of its preparation and use. The invention is further related to compositions comprising trimetrexate ascorbate, to compositions comprising trimetrexate and ascorbic acid, and to
BACKGROUND OF THE INVENTION
Throughout this application various publications are referenced by arabic numerals within parentheses. Full citations for these publications may be found at the end of the specification immediately preceding the claims. The disclosures of these publications in their